John Libbey Eurotext

European Journal of Dermatology

Nivolumab-induced vitiligo successfully treated with narrowband UVB phototherapy Article à paraître

Illustrations

  • Figure 1
Auteurs
1 Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
2 Department of Dermatology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa 216-8511, Japan

Anti-programmed cell death (PD)-1 therapy is presently becoming a new standard immunotherapeutic procedure not only for metastatic melanoma, but also for other metastatic cancers, such as non-small cell lung cancer and renal cell carcinoma. It is important to be aware of adverse events (AEs) of anti-PD-1 therapy, and vitiligo is a main dermatological AE, along with skin rash and pruritus. Vitiligo can be associated with a better outcome in melanoma patients [1], but this has been poorly studied due [...]